Total Payments
$1,137
2024 Payments
$182.43
Companies
9
Transactions
53
Medicare Patients
2,426
Medicare Billing
$127,275
Payment Breakdown by Category
Food & Beverage$1,137 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,137 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $395.80 | 15 | $0 (2022) |
| ABBVIE INC. | $366.70 | 21 | $0 (2024) |
| Oyster Point Pharma, Inc. | $129.46 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $68.71 | 3 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $68.65 | 4 | $0 (2022) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $44.98 | 2 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $21.63 | 1 | $0 (2022) |
| Valeant Pharmaceuticals North America LLC | $21.18 | 1 | $0 (2017) |
| Shire North American Group Inc | $19.52 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $182.43 | 12 | ABBVIE INC. ($182.43) |
| 2023 | $212.29 | 9 | AbbVie Inc. ($127.55) |
| 2022 | $210.74 | 11 | ABBVIE INC. ($56.72) |
| 2021 | $82.13 | 4 | Allergan, Inc. ($39.67) |
| 2020 | $84.63 | 5 | Allergan, Inc. ($84.63) |
| 2019 | $145.55 | 5 | Allergan Inc. ($58.43) |
| 2018 | $37.81 | 2 | Allergan Inc. ($37.81) |
| 2017 | $181.05 | 5 | Allergan Inc. ($140.35) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: EYE CARE | ||||||
| 11/04/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: EYE CARE | ||||||
| 10/08/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: EYE CARE | ||||||
| 06/06/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: EYE CARE | ||||||
| 05/14/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: EYE CARE | ||||||
| 04/18/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: EYE CARE | ||||||
| 04/18/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $3.49 | General |
| Category: EYE CARE | ||||||
| 04/01/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: EYE CARE | ||||||
| 03/05/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: EYE CARE | ||||||
| 02/01/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: EYE CARE | ||||||
| 01/18/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: EYE CARE | ||||||
| 01/04/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: EYE CARE | ||||||
| 12/18/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: EYE CARE | ||||||
| 11/21/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: EYE CARE | ||||||
| 10/17/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: EYE CARE | ||||||
| 09/12/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: DRY EYE | ||||||
| 07/26/2023 | AbbVie Inc. | ALPHAGAN P (Drug), LUMIGAN | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: EYE CARE | ||||||
| 07/13/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $32.77 | General |
| Category: DRY EYE | ||||||
| 04/12/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: DRY EYE | ||||||
| 04/05/2023 | AbbVie Inc. | ALPHAGAN P (Drug), LUMIGAN | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: EYE CARE | ||||||
| 01/24/2023 | AbbVie Inc. | ALPHAGAN P (Drug), LUMIGAN | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: EYE CARE | ||||||
| 12/14/2022 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Ophthalmology | ||||||
| 12/01/2022 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/18/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Ophthalmology | ||||||
| 10/11/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: DRY EYE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 670 | 726 | $108,440 | $34,726 |
| 2022 | 8 | 536 | 573 | $83,705 | $27,736 |
| 2021 | 8 | 627 | 684 | $90,825 | $33,134 |
| 2020 | 6 | 593 | 641 | $84,480 | $31,679 |
Total Patients
2,426
Total Services
2,624
Medicare Billing
$127,275
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 189 | 189 | $38,745 | $12,691 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 189 | 220 | $19,800 | $11,233 | 56.7% |
| 92250 | Photography of the retina | Office | 2023 | 128 | 134 | $22,780 | $2,867 | 12.6% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 43 | 43 | $10,105 | $2,783 | 27.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 36 | 53 | $3,180 | $1,944 | 61.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $4,290 | $1,647 | 38.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 22 | 22 | $3,190 | $717.12 | 22.5% |
| 92134 | Imaging of retina | Office | 2023 | 17 | 19 | $2,850 | $482.12 | 16.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 20 | 20 | $3,500 | $360.08 | 10.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 175 | 199 | $17,910 | $10,331 | 57.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 142 | 142 | $29,110 | $10,155 | 34.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 57 | 57 | $8,265 | $2,421 | 29.3% |
| 92250 | Photography of the retina | Office | 2022 | 97 | 100 | $17,000 | $2,318 | 13.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 20 | 20 | $4,700 | $1,043 | 22.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 22 | $1,320 | $838.22 | 63.5% |
| 92134 | Imaging of retina | Office | 2022 | 15 | 15 | $2,250 | $316.34 | 14.1% |
| 92133 | Imaging of optic nerve | Office | 2022 | 17 | 18 | $3,150 | $313.73 | 10.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 164 | 164 | $26,330 | $10,895 | 41.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 105 | 151 | $13,590 | $8,423 | 62.0% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 132 | 132 | $12,120 | $6,552 | 54.1% |
| 92250 | Photography of the retina | Office | 2021 | 132 | 140 | $23,800 | $3,278 | 13.8% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 30 | 30 | $5,730 | $2,125 | 37.1% |
| 92002 | Eye and medical examination for diagnosis and treatment, new patient | Office | 2021 | 28 | 28 | $3,355 | $1,004 | 29.9% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 24 | 25 | $3,800 | $533.40 | 14.0% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 12 | 14 | $2,100 | $323.62 | 15.4% |
About Dr. Troy Avery, O.D
Dr. Troy Avery, O.D is a Optometrist healthcare provider based in Lewiston, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497857429.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Troy Avery, O.D has received a total of $1,137 in payments from pharmaceutical and medical device companies, with $182.43 received in 2024. These payments were reported across 53 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,137).
As a Medicare-enrolled provider, Avery has provided services to 2,426 Medicare beneficiaries, totaling 2,624 services with total Medicare billing of $127,275. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Lewiston, ME
- Active Since 09/01/2006
- Last Updated 07/08/2007
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1497857429
Products in Payments
- LUMIGAN (Drug) $414.08
- TYRVAYA (Drug) $129.46
- VUITY (Drug) $73.76
- XIIDRA (Drug) $67.84
- ALPHAGAN P (Drug) $65.54
- Cequa (Drug) $48.14
- VYZULTA (Drug) $44.95
- COMBIGAN (Drug) $37.81
- RESTASIS (Drug) $35.22
- INFUSE (Device) $21.66
- BESIVANCE (Drug) $21.18
- XELPROS (Drug) $20.51
- DUREZOL (Drug) $20.39
- RESTASIS MULTIDOSE (Drug) $14.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Lewiston
Dr. Daniel Evans, O.d, O.D
Optometrist — Payments: $3,923
Optometrist $3,923
Hannah Medwin, Od, OD
Optometrist — Payments: $2,764
Optometrist $2,764
Dr. Kevin Komm, O.d, O.D
Optometrist — Payments: $2,692
Optometrist $2,692
Dr. Douglas Henry, O.d, O.D
Optometrist — Payments: $1,581
Optometrist $1,581
Sheridon Gove, O.d, O.D
Optometrist — Payments: $665.91
Optometrist $665.91
Dr. Daniel Schrempp, Od, OD
Optometrist — Payments: $640.95
Optometrist $640.95